... hypofractionated 3- dimensional radiation therapy for inoperable, early stage non- smallcelllung cancer Sergio L Faria*1, Luis Souhami1, Lorraine Portelance1, Marie Duclos1, Te Vuong1, David Small 2 ... as lung cancer. It is more convenient for the patients and reduces health care costs.This study reports our results on patients with medically inoperable, early stage, non- smallcell lung cancer ... hypofractionated radiation therapyis an attractive option for patients with early stage non- small celllungcancer (NSCLC) who are not surgical can-didates. Although primarily appealing for...
... iotherapy, Oligometastases, Non- SmallCellLung Cancer Background Non- smallcelllungcancer (NSCLC) is the leadingcause of cancer mortality in the United States [1].Patients with stage IV NSCLC typically ... of 7 RESEARC H Open AccessComparison of outcomes in patients with stage IIIversus limited stage IV non- smallcelllung cancer Praveena Cheruvu1, Su K Metcalfe1, Justin Metcalfe1, Yuhchyau ... with NSCLC: stage III, stage IV, andrecurrent stage IV (initial stage I-II). All stage IV NSCLC patients treated with SBRT had ≤ 8 lesions.Results: Of 146 patients, 88% had KPS ≥ 80%, 30 % had >...
... peripheral stage I non- smallcelllung cancer. LungCancer 1999, 26: 137 -142. 23. Slotman BJ, Antonisse IE, Njo KH: Limited field irradiation inearly stage (T1-2N0) non- smallcelllung cancer. RadiotherOncol ... involving single-dose irradiation. With 25patients, 31 metastases in the lungs were irradiated; with each of 33 patients, stage I non- small cell lungcancer (NSCLC) was subject to irradiation. The ... WannenmacherM, Debus J: Stereotactic single-dose radiotherapy of stage I non- small- celllungcancer (NSCLC). Int J Radiat Oncol Biol Phys20 03, 56 :33 5 -34 1.16. Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller...
... Res. 19 93; 13( 4): 1 133 -7. 83. Ohsaki Y, Tanno S, Fujita Y, et al. Epidermal growth factor re-ceptor expression correlates with poor prognosis in non- small cell lungcancer patients with p 53 overexpression. ... ZD1 839 ) in non- small- celllung can-cer. Br J Cancer. 2004; 91(2): 208-12. 89. Bailey R, Kris M, Wolf M. Gefitinib (Iressa, ZD 1 839 ) mono-therapy for pretreated advanced non- smallcelllungcancer ... in non- small cell lungcancer Is correlated with survival. Clin Cancer Res. 2001; 7(7): 1850-5. 93. Cappuzzo F, Gregorc V, Rossi E, et al. Gefitinib in pretreated non- small- celllung cancer...
... agentdocetaxel in a patient with advanced non small celllung cancer Ferdinando Riccardi1*, Giuseppe Di Lorenzo1, Carlo Buonerba1, Guglielmo Monaco2, Roberto Monaco 3 ,Mimma Rizzo1, Sarah Scagliarini1, ... Carteni’1AbstractBackground: Defining the optimal treatment for patients with inoperable nonsmallcelllungcancer (NSCLC),presenting with metastatic mediastinal lymph nodes, is challenging. Nevertheless, ... few cycles should notautomatically discourage to continue treatment.IntroductionIn non- smallcelllungcancer (NSCLC), mediastinallymphnode involvement comprises a wide spectrum ofseverity....
... planning CT images was170 cm 3 (range 25 cm 3 - 35 3 cm 3 ); the GTV volumedecreased to median 124 cm 3 (19 cm 3 - 32 5 cm 3 ) and 100cm 3 (10 cm 3 - 270 cm 3 ) mid-way and at the end of ... was observed with median GTV volumes of 170 cm 3 (range 42 cm 3 - 35 3 cm 3 ), 124 cm 3 (19 cm 3 - 32 5 cm 3 ) and 100 cm 3 (10 cm 3 - 270 cm 3 ) at treatmentplanning, mid-way and at the end ... 5.7Carina 6.0 ± 3. 2 10 4.5 ± 2.5 6.5Pulmonary landmarks - same lobe as GTV8 .3 ± 3. 8 15 5.5 ± 2 .3 11Pulmonary landmarks - different lobes as GTV8.0 ± 3. 8 13 6 .3 ± 2.8 13 Radiation Oncology...